Octarine Bio, a Danish BioTech firm growing a brand new era of sustainable pigments by means of precision fermentation, has efficiently secured €5 million to speed up the industrial-scale validation and business rollout of PurePalette, their pure pigment platform.
The spherical was supported by present buyers and joined by new companions, together with The Footprint Agency, Edaphon, Unconventional Ventures, DSM-Firmenich Ventures, Oskare Capital, in addition to a number of enterprise angels, amongst them Per Falholt and Steen Riisgaard, former CSO and CEO of Novozymes (now Novonesis). This brings its complete Sequence A elevate to €12.8 million, together with earlier pre-Sequence A financing.
Commenting on the milestone, Nethaji Gallage, CEO and co-founder of Octarine Bio, says: “The completion of our Sequence A is a pivotal step for Octarine. It permits us to scale manufacturing of our first three flagship PurePalette colors, execute on business partnerships already in place, and develop product growth of our protected and sustainable pigments into new industries. We deeply admire the unwavering help from our present buyers and are excited to welcome new companions who carry extra industry-relevant capabilities.”
Octarine Bio’s Sequence A extension matches right into a broader sample of 2025/2026 European funding exercise in artificial biology and sustainable supplies, as lined by EU-Startups.
In Might 2025, Solena Materials, a London-based firm growing synthetic-biology-enabled textiles, raised €5.9 million in Seed funding to scale manufacturing of next-generation sustainable materials. Extra broadly inside industrial and enabling BioTech, Helsinki-based Avenue Biosciences secured €4.8 million in early-stage funding in January 2026 to develop its protein engineering and manufacturing instruments, underlining sustained capital deployment into platform applied sciences that help scalable organic manufacturing.
Taken collectively, these rounds symbolize roughly €10.7 million in disclosed funding throughout adjoining sectors, offering context for Octarine Bio’s financing as a part of a wider, albeit selective, circulation of capital into European artificial biology and sustainable supplies ventures throughout 2025 and 2026.
Anna Zimmermann, Senior Affiliate, Edaphon provides: “PurePalette has the potential to drastically scale back the environmental impression of textile dyeing, one of the vital polluting steps within the textile worth chain. By becoming into present dyeing processes, the pigments could be broadly adopted and drive significant change throughout the {industry}. We’re excited to help the staff as they transfer into this subsequent part.”
Based in 2018, Octarine Bio is an artificial biology firm, engineering microbial techniques to supply bio-based pigments with a confirmed low environmental impression. By proprietary fermentation and biocatalysis platforms, Octarine Bio reportedly creates high-performance alternate options to fossil-based dyes, designed to combine instantly into present textile manufacturing techniques.
In response to PurePalette, they’re the {industry}’s solely totally bio-based color platform able to delivering your entire color spectrum by means of a single manufacturing course of, providing excessive color power, efficiency, and stability, whereas sustaining a confirmed low environmental impression.
PurePalette colors possess distinctive properties enabling use in functions spanning a number of enterprise areas, starting from textile, meals and beverage, cosmetics and plenty of extra.
Jonas Ahm-Lundgren, Associate, The Footprint Agency mentioned: “We’re thrilled to proceed backing Octarine in bringing their groundbreaking know-how to market.The staff is world-class, and the potential for bio-based color within the textile house and past is gigantic.”
